Toru. Kimura, et.al., Treatment with alpha-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis., Journal of immunology (Baltimore, Md. : 1950), 2004, 172

http://rdf.ncbi.nlm.nih.gov/pubmed/15100325

Toru. Kimura, et.al., Treatment with alpha-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis., Journal of immunology (Baltimore, Md. : 1950), 2004, 172

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased NK T cell number_Tcra-J<tm1Tgi>/Tcra-J<tm1Tgi>
  http://metadb.riken.jp/0008040I129S1Sv129X1SvJC57BL6TcraJtm1TgiTcraJtm1TgiTcraJtm1Tgi
• lung inflammation_Tcra-J<tm1Tgi>/Tcra-J<tm1Tgi>
  http://metadb.riken.jp/0001861I129S1Sv129X1SvJC57BL6TcraJtm1TgiTcraJtm1TgiTcraJtm1Tgi
• increased sensitivity to xenobiotic induced morbidity/mortality_Tcra-J<tm1Tgi>/Tcra-J<tm1Tgi>
  http://metadb.riken.jp/0009766I129S1Sv129X1SvJC57BL6TcraJtm1TgiTcraJtm1TgiTcraJtm1Tgi
• pulmonary fibrosis_Tcra-J<tm1Tgi>/Tcra-J<tm1Tgi>
  http://metadb.riken.jp/0006050I129S1Sv129X1SvJC57BL6TcraJtm1TgiTcraJtm1TgiTcraJtm1Tgi